Skip to content
The Longevity Archive
BPC-157 in all countries

Legal status · Australia

Is BPC-157 legal in Australia?

Not approvedHealing & RecoveryEvidence: Preliminary

No. BPC-157 is not an approved medicine in Australia; its classification is "Prohibited in sport (WADA S0); not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.

BPC-157 in Australia at a glance

ClassificationProhibited in sport (WADA S0); not approved
TGA approval statusNot approved by TGA
Evidence levelPreliminary (research strength: Preliminary)
ReviewedSep 2026

Classification and note come from the BPC-157 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    No product containing BPC-157 is approved by TGA for any use in Australia, so nothing on the market is authorized for people.

  • 02

    "Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.

  • 03

    Importing, supplying or promoting it for human use can fall under medicines legislation in Australia. This page is general information, not legal advice.

What BPC-157 is

A pentadecapeptide studied extensively in animal models for tendon, ligament, muscle, and gut healing. Human evidence remains limited.

BPC-157 is a synthetic peptide derived from a protein found in gastric juice. It has been studied heavily in rodent models for regenerative effects on connective tissue and the gastrointestinal tract.

Mechanism: In animal studies it appears to promote angiogenesis, modulate the nitric oxide system, and upregulate growth factor signaling involved in tissue repair. Human mechanistic data are limited.

Regulatory history: Not FDA-approved. Removed from Category 2 (April 2026); PCAC voted 8 to 6 to recommend for compounding (July 2026); awaiting FDA rulemaking

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for BPC-157 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

BPC-157 in other countries

Frequently asked questions

Is BPC-157 legal in Australia?

No. BPC-157 is not an approved medicine in Australia; its classification is "Prohibited in sport (WADA S0); not approved". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. Human evidence: Preliminary.

Can I buy BPC-157 in Australia?

No approved product exists to buy. In Australia BPC-157 is classified as "Prohibited in sport (WADA S0); not approved", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is BPC-157 TGA approved?

No. In Australia BPC-157 is classified as "Prohibited in sport (WADA S0); not approved", which is not a TGA marketing approval. For comparison, the US FDA status is: Not FDA-approved. Removed from Category 2 (April 2026); PCAC voted 8 to 6 to recommend for compounding (July 2026); awaiting FDA rulemaking. Evidence level: Preliminary.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for BPC-157 live on its compound profile.

BPC-157 profile

This page is general information about the regulatory status of BPC-157 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.